Pharma Industry

Content Creation
Agency for Pharma

Product monographs, capability documents and certification content written for people who read specification sheets for a living.

4.9/5(100+ Reviews)

Trusted by

/ Our Approach

Growing Pharma brands with Content Creation since 2017.

The most valuable content a pharmaceutical manufacturer owns is already written. It sits in specification sheets, certificates of analysis, plant licences, stability summaries and dossier indexes, locked inside PDFs that nobody outside your regulatory team ever reads. Content work here is not blogging. It is converting that technical material into structured, readable, releasable pages that a sourcing manager can evaluate at eleven at night without calling you, and building the supporting layer around it: dosage form capability write-ups, certification explainers, therapeutic division profiles and franchise material. Every line has to survive review by a regulatory head who is personally accountable if a claim goes too far.

Content for a pharmaceutical manufacturer has an unusual property: the source material is already authored, already accurate and already approved, but it is unreadable and unfindable. A typical formulation business holds hundreds of pages of specification material in PDF form, almost none of it on an indexable page. Converting that into structured product monographs is normally the single highest-value content project available, because it simultaneously serves search, serves AI assistants that procurement teams now use for supplier discovery, and shortens the qualification call. Around that core sit three supporting tracks that do not share a writer or a reviewer. Capability content for contract manufacturing and licensing buyers is written for a technical evaluator and reviewed by production and quality. Franchise and distributor material is written for an entrepreneur and reviewed by sales. Export documentation content is written for a regulatory affairs counterpart and reviewed by your regulatory head. The constraint shaping all of it is that a manufacturer cannot make therapeutic or comparative efficacy claims in openly accessible material, or promote prescription products to the public in India. Welbourg Pharma is a published pharmaceutical client of ours. We have worked with multiple brands in this category since 2017 and can share specific names and numbers on request.

100+

Projects Delivered

90%+

Success Rate

3X ROI

ROI

25+

Team Experts

/ Why Baclinc

Why Pharma brands choose us for Content Creation.

View our work

Product Monographs As The Core Asset

For each molecule and dosage form we produce a structured page covering composition, strength and pack configuration, therapeutic category, manufacturing plant, applicable certifications, shelf life and storage, and documentation availability. This is the format a procurement buyer actually reads, and it is what a forty word marketplace listing cannot compete with.

Written From Your Documents, Not From The Internet

We work from your specification sheets, certificates, plant licences and dossier indexes rather than paraphrasing competitor websites or generic pharmacopoeial text. That means an intake process with your regulatory and quality teams, and it means the output is accurate enough that they are willing to sign it off.

Regulatory Review Built Into The Workflow

Nothing publishes without a compliance pass against DCGI rules and the Drugs and Magic Remedies Act, and nothing publishes without your quality or regulatory head approving it. We write efficacy language onto the specification and the documentation rather than onto outcome promises, because that is the line that keeps a manufacturer safe.

Capability Content For Contract Manufacturing Buyers

A CDMO or third party manufacturing buyer is not evaluating a product, they are evaluating you. That needs a different content set: dosage form capability write-ups, line and capacity detail, technology transfer process, analytical and stability support, regulatory support scope, and how confidentiality and intellectual property are handled during evaluation.

Franchise And Distributor Material As Its Own Track

PCD franchise and distributor recruitment content is commercial rather than technical. Division profiles, product range lists with pricing structure, monopoly rights terms, promotional input support and minimum order expectations, written plainly enough that an unsuitable applicant disqualifies themselves before they reach your phone.

Export Documentation Content

Overseas buyers evaluate you on paperwork before product. We build a documentation-first layer covering dossier availability and format, CEP and DMF status where applicable, registration support scope, which markets you already hold approvals in, and realistic minimum order quantities and lead times, since vague commercial terms are the most common reason a serious export enquiry goes quiet.

/ Real Results

Featured Success Stories

View All Case Studies

Welbourg Pharma2026

Welbourg Pharma - Website Development

Welbourg Pharma2026

Welbourg Pharma - Social Media Content

How We Work

Our Proven Process

Document Intake And Audit

We collect your specification sheets, certificates, plant licences, dossier indexes and existing catalogue, then map what is releasable, what is confidential and what is out of date. Most manufacturers discover the published catalogue disagrees with the current product master.

Product Monograph Template

We agree one structured format covering composition, strength, pack, therapeutic category, plant, certifications, shelf life, storage and documentation availability, so the whole catalogue is consistent and comparable rather than written differently product by product.

Catalogue Conversion

Molecule by molecule and form by form, PDF content becomes a readable HTML page with the specification rendered as text, the original PDF kept alongside as a download for buyers who want to circulate it internally.

Capability And Division Layer

Dosage form capability write-ups, line and capacity detail, technology transfer and analytical support for CDMO buyers, plus therapeutic division profiles for franchise and distributor recruitment, each written for its own reader.

Regulatory And Quality Sign-Off

Every asset goes through a compliance pass against DCGI and Drugs and Magic Remedies restrictions and then to your quality or regulatory head for approval, with claims tied to documentation rather than to outcomes.

Maintenance Cycle

Certificates expire, plants get added, products get discontinued and pack sizes change. We run a scheduled review so the published catalogue keeps matching the product master, because a wrong strength or a lapsed certificate on a live page is a commercial problem.

/ Testimonials

What our clients say

"Great experience working with the team. Very good results in less time and very proactive in responding to queries. Kudos to the team👍🏻"

Saad Khan

Founder, RebelCorp

"i've worked with this SEO agency and still up to now, they understand the SEO factors and thinking out of the box."

Sydney Ifergan

Trade.com

"Abhishek is super-professional in his approach and a delight to collaborate with! He works WITH you to help you overcome challenges and achieve desired objectives. Great partner to work with!"

Ravi Raj

Director, Skillaroo

"We, at The Club Mumbai, had a great experience working with Abhishek from Baclinc. Right from designing our website to hosting it, working on SEO, coming up with nitty-gritty of digital marketing, we had constant support and advise from the team."

Samir Gupte

HOM, The Club Mumbai

"It has truly been a pleasure working with Baclinc. I wanted to take a moment to express my sincere gratitude for your dedication and support throughout the website development process."

Sandeep Shinde

Marketing Manager, Enlite Research

"We have worked with Baclinc for our website design and development services and are happy with the output delivered, the team works very professionally and helped us ideate the best designs to our liking. I would recommend Baclinc as a website design agency to any enterprise."

Fazlani Group

"Great experience working with the team. Very good results in less time and very proactive in responding to queries. Kudos to the team👍🏻"

Saad Khan

Founder, RebelCorp

"i've worked with this SEO agency and still up to now, they understand the SEO factors and thinking out of the box."

Sydney Ifergan

Trade.com

"Abhishek is super-professional in his approach and a delight to collaborate with! He works WITH you to help you overcome challenges and achieve desired objectives. Great partner to work with!"

Ravi Raj

Director, Skillaroo

Samir Gupte

HOM, The Club Mumbai

"It has truly been a pleasure working with Baclinc. I wanted to take a moment to express my sincere gratitude for your dedication and support throughout the website development process."

Sandeep Shinde

Marketing Manager, Enlite Research

Fazlani Group

Common Questions

Everything you need to know about Content Creation for Pharma brands

What content does a pharma manufacturer actually need?

A structured product monograph for every molecule and dosage form you sell, and that is the priority before anything else. Around it sit three supporting sets: capability content for contract manufacturing and licensing buyers, division and range material for PCD franchise and distributor recruitment, and documentation-led content for export buyers covering dossier availability and registration support. Blog articles rank far below all of these. If your catalogue is currently a PDF, converting it is the work that changes your commercial surface most.

Can you write disease awareness or patient education content?

Only in a strictly unbranded form, and it is rarely where a manufacturer should spend. Indian rules restrict promotion of prescription products to the general public and the Drugs and Magic Remedies Act restricts claims around a specified list of conditions, so branded patient-facing content is not an option for a scheduled product. Unbranded awareness material is permissible but it reaches patients, and patients do not place purchase orders with a manufacturer. For a supply-side business the commercial value sits in procurement, licensing, distribution and export content.

Who writes and who approves the technical content?

We write from your source documents and your regulatory or quality head approves before publish, and we will not ship without that approval. Our writers work from specification sheets, certificates and dossier indexes supplied by you, not from competitor sites or general pharmacopoeial text, and we run structured intake sessions with your technical team to fill gaps. The approval step is non-negotiable in this category, because the person carrying regulatory accountability has to be the person who signs off what is published under your name.

Our specification data is confidential. How is that handled?

We work under a confidentiality agreement and we publish only what you mark as releasable. In practice we split the material into three tiers during intake: openly publishable specification, material released to identified buyers on request, and material that never leaves under any circumstance. The published monograph carries the first tier and then states clearly what further documentation is available on request and under what terms, which is itself a useful signal to a serious buyer and a useful filter against casual enquiries.

Have you produced content for pharmaceutical companies?

Yes. Welbourg Pharma is a pharmaceutical client of ours, with published work on our site covering website development and social media content. We have also worked with multiple brands in this category since 2017 and can share specific names and numbers on request. Our broader portfolio runs to 150+ brands since 2017, and the most relevant adjacent experience for a manufacturer is our B2B industrial content work, where specification depth rather than persuasive writing is what closes the enquiry.

How many pieces per month should we expect?

Catalogue conversion is a project with a defined end, not a monthly subscription, and that distinction matters for budgeting. Converting a hundred product monographs is front-loaded work that runs across a few months and then largely stops. After that the ongoing requirement is modest: new product additions, certification updates, capability content as you commission new lines, and periodic accuracy review. We would rather quote the conversion as a project and keep the retainer small than sell you a content calendar you do not need.

Will you use AI to write our product pages?

Not for technical specification content, and this is a firm position. A language model asked to write a product monograph will produce plausible strengths, plausible shelf life and plausible certification claims that are not yours, and in a regulated category that is a liability rather than an efficiency. We use AI for structural drafting and formatting assistance where a human is verifying every figure against your source document. The specification numbers themselves come from your paperwork and are checked by your team.

Do you write in languages other than English?

English is the working language for technical and export material, and that is generally the right choice. Procurement, regulatory and licensing communication in Indian pharma runs in English, and dossier and specification content has to match the language of the documentation it describes. Where regional language content genuinely helps is franchise and distributor recruitment, since district-level distribution prospects often research in Hindi or a regional language. We can arrange that for the franchise track specifically rather than translating the technical catalogue.